{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:02:09Z","timestamp":1784286129203,"version":"3.55.0"},"reference-count":12,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Jiading district","award":["JDKW-2022-0037"],"award-info":[{"award-number":["JDKW-2022-0037"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Zinc Finger and BTB Domain-containing7A (ZBTB7A) is a member of the transcription factor family that regulates the expression of numerous genes involved in cell proliferation and differentiation. Ubiquitously expressed in colon, stomach, and other tissues, ZBTB7A performs diverse functions including hematopoiesis, metabolism, and oncogenesis. Here we showed that ZBTB7A knockout inhibited the growth of colon cancer cells and reduced CD95 protein expression by decreasing CD95 mRNA transcription. Overexpression of ZBTB7A could partially restore both CD95 expression and CD95-mediated downstream Caspase2 and JNK2 expression. Furthermore, treatment with ZBTB7A specific inhibitor Curcumin effectively induced colorectal cancer cell death while reducing CD95 expression. These data indicate that ZBTB7A promotes colon cancer cell growth and survival, suggesting its potential as a therapeutic target for colorectal cancer.<\/jats:p>","DOI":"10.1371\/journal.pone.0329958","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:23:03Z","timestamp":1757956983000},"page":"e0329958","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines"],"prefix":"10.1371","volume":"20","author":[{"given":"Yanhong","family":"Bie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5752-0063","authenticated-orcid":true,"given":"Linlin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"pone.0329958.ref001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"RL Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"pone.0329958.ref002","doi-asserted-by":"crossref","first-page":"1032314","DOI":"10.3389\/fimmu.2022.1032314","article-title":"Predictive biomarkers of colon cancer immunotherapy: present and future","volume":"13","author":"W Hou","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"pone.0329958.ref003","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1007\/s11033-021-06405-x","article-title":"Role of ZBTB7A zinc finger in tumorigenesis and metastasis","volume":"48","author":"AK Singh","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"7","key":"pone.0329958.ref004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/cbf.3287","article-title":"LRF inhibits p53 expression in colon cancer cells via modulating DAP5 activity","volume":"35","author":"M Zhu","year":"2017","journal-title":"Cell Biochem Funct"},{"key":"pone.0329958.ref005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092125","article-title":"The role of p53 signaling in colorectal cancer","volume":"13","author":"MC Liebl","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0329958.ref006","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"A Strasser","year":"2009","journal-title":"Immunity"},{"issue":"7297","key":"pone.0329958.ref007","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature09075","article-title":"CD95 promotes tumour growth","volume":"465","author":"L Chen","year":"2010","journal-title":"Nature"},{"issue":"1","key":"pone.0329958.ref008","first-page":"189","article-title":"CD95 signaling in colorectal cancer","volume":"1826","author":"FJH Hoogwater","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"pone.0329958.ref009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.celrep.2014.02.035","article-title":"Death induced by CD95 or CD95 ligand elimination","volume":"7","author":"A Hadji","year":"2014","journal-title":"Cell Reports"},{"issue":"4","key":"pone.0329958.ref010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cdd.2015.3","article-title":"The role of CD95 and CD95 ligand in cancer","volume":"22","author":"ME Peter","year":"2015","journal-title":"Cell Death Differ"},{"issue":"3","key":"pone.0329958.ref011","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s11033-009-9575-6","article-title":"Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells","volume":"37","author":"J Cui","year":"2010","journal-title":"Mol Biol Rep"},{"issue":"1","key":"pone.0329958.ref012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bph.12432","article-title":"JNK signalling in cancer: in need of new, smarter therapeutic targets","volume":"171","author":"C Bubici","year":"2014","journal-title":"Br J Pharmacol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:23:06Z","timestamp":1757956986000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329958"}},"subtitle":[],"editor":[{"given":"Roy P.","family":"Planalp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0329958","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}